Literature DB >> 18691485

Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.

Hae Suk Cheong1, Cheol-In Kang, Yu Mi Wi, Eun Seok Kim, Jin Seo Lee, Kwan Soo Ko, Doo Ryeon Chung, Nam Yong Lee, Jae-Hoon Song, Kyong Ran Peck.   

Abstract

BACKGROUND: Pseudomonas aeruginosa bacteremia is a serious and possibly fatal condition. It is important to determine the likelihood of P. aeruginosa bacteremia when Gram-negative sepsis is suspected in community-onset infection.
METHODS: We performed a retrospective cohort study to identify the risk factors for P. aeruginosa infection in community-onset Gram-negative bacteremia.
RESULTS: A total of 106 patients with P. aeruginosa bacteremia and a total 508 patients with E. coli bacteremia were included in this study. Factors associated with P. aeruginosa bacteremia in the multivariate analysis included presentation with neutropenia, presentation with septic shock, indwelling central venous catheter, and health-care-associated infection (all P <.05). The 30-day mortality rate was 26.4% in patients with P. aeruginosa and 13.6% in those with E. coli bacteremia (P <.001). Multivariate analysis demonstrated that risk factors for mortality included a P. aeruginosa bacteremia, inappropriate initial antimicrobial therapy, a higher Charlson's weighted index of comorbidity, and a higher Pitt bacteremia score (all P <.05). In addition, urinary tract infection and benign pancreatobiliary disease were found to be protective factors for mortality based on multivariate analysis (all P <.05).
CONCLUSIONS: Our data suggest that initial empirical antimicrobial coverage of P. aeruginosa should be seriously considered in patients with neutropenia, presentation with septic shock, indwelling central venous catheter, or health-care-associated infection, when Gram-negative sepsis is suspected in community-onset infection.

Entities:  

Mesh:

Year:  2008        PMID: 18691485     DOI: 10.1016/j.amjmed.2008.03.034

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  23 in total

1.  The Natural Product Elegaphenone Potentiates Antibiotic Effects against Pseudomonas aeruginosa.

Authors:  Weining Zhao; Ashley R Cross; Caillan Crowe-McAuliffe; Angela Weigert-Munoz; Erika E Csatary; Amy E Solinski; Joanna Krysiak; Joanna B Goldberg; Daniel N Wilson; Eva Medina; William M Wuest; Stephan A Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2019-05-16       Impact factor: 15.336

2.  Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI.

Authors:  M N Al-Hasan; J E Eckel-Passow; L M Baddour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-08       Impact factor: 3.267

3.  Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis.

Authors:  Sarah E Cain; Joseph Kohn; P Brandon Bookstaver; Helmut Albrecht; Majdi N Al-Hasan
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.

Authors:  Elizabeth B Nimmich; P Brandon Bookstaver; Joseph Kohn; Julie Ann Justo; Katie L Hammer; Helmut Albrecht; Majdi N Al-Hasan
Journal:  Hosp Pharm       Date:  2017-07-21

5.  The ability of quaternary ammonium groups attached to a urethane bandage to inhibit bacterial attachment and biofilm formation in a mouse wound model.

Authors:  Phat L Tran; Eric Huynh; Abdul N Hamood; Anselm de Souza; Gregory Schultz; Bernd Liesenfeld; Dilip Mehta; Daniel Webster; Ted W Reid
Journal:  Int Wound J       Date:  2015-12-28       Impact factor: 3.315

6.  Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.

Authors:  Cheol-In Kang; Jae-Hoon Song; Kwan Soo Ko; Doo Ryeon Chung; Kyong Ran Peck
Journal:  Support Care Cancer       Date:  2011-02-12       Impact factor: 3.603

7.  Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.

Authors:  Cheol-In Kang; Jae-Hoon Song; Doo Ryeon Chung; Kyong Ran Peck; Joon-Sup Yeom; Jun Seong Son; Yu Mi Wi
Journal:  Support Care Cancer       Date:  2011-12-23       Impact factor: 3.603

8.  Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.

Authors:  Ali A El-Solh; Angela Hattemer; Alan R Hauser; Ahmad Alhajhusain; Hardik Vora
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

9.  Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.

Authors:  Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan
Journal:  Infection       Date:  2018-05-11       Impact factor: 3.553

10.  Organoselenium coating on cellulose inhibits the formation of biofilms by Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Phat L Tran; Adrienne A Hammond; Thomas Mosley; Janette Cortez; Tracy Gray; Jane A Colmer-Hamood; Mayank Shashtri; Julian E Spallholz; Abdul N Hamood; Ted W Reid
Journal:  Appl Environ Microbiol       Date:  2009-04-03       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.